REGISTER HERE.

CMHC Masterclass is a series of CME/CE live and archived online learning events directly connecting attendees to the foremost experts in cardiometabolic health from the setting of their choosing. Through an interactive and easy-to-navigate online format, CMHC Masterclass will provide the opportunity to join world-renowned clinical practitioners, researchers, and educators in taking a deep investigative dive into the latest knowledge in cardiometabolic health available.

The increasing rates of obesity, diabetes, and metabolic syndrome in the United States are leading to more cases of non-alcoholic fatty liver disease (NAFLD) and its most aggressive subtype, non-alcoholic steatohepatitis (NASH), which are now being encountered at a greater frequency in clinical practice. NASH can lead to significant morbidity and mortality, including liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC)—in fact, HCC caused by NASH is poised to become the leading cause of liver transplants in the US

AGENDA

• Current and Emerging Diagnostic Tools: From NAFLD to NASH to Fibrosis
• How and Whom to Screen for NAFLD/NASH
• NASH Recognition and Diagnosis: Who is Responsible? Expert Panel Discussion
• Existing NASH Treatments
• Making Sense of the NASH Pipeline
• Who Should Treat NASH? The Importance of Extending Care Beyond The Liver and GI Specialists Expert Panel Discussion

CME/CE Certified Education

Both the live and archived educational sessions will be certified for ACCME, ANCC, and ACPE credits.

For more information visit the official event page.